VERA - Guggenheim starts Vera at buy sees IgAN drug as well positioned
2023-08-16 14:06:02 ET
More on Vera Therapeutics
- Vera: New Kidney Data, May Be A Potential Next Big Pharma M&A Target
- Vera: Repurposed Molecule Program Does Not Impress
- Novartis deal to buy Chinook rallies Vera Therapeutics
- Vera Therapeutics slips on $75M stock offering
- Vera Therapeutics boasts of mid-stage data from kidney inflammation candidate atacicept
- Vera Therapeutics downgraded to neutral at Wedbush following atacicept data setback
- Seeking Alpha’s Quant Rating on Vera Therapeutics
- Earnings data for Vera Therapeutics
For further details see:
Guggenheim starts Vera at buy, sees IgAN drug as "well positioned"